SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-266322
Filing Date
2022-10-21
Accepted
2022-10-21 07:06:00
Documents
6
Period of Report
2022-10-21

Document Format Files

Seq Description Document Type Size
1 6-K d372513d6k.htm 6-K 10334
2 EX-99.1 d372513dex991.htm EX-99.1 27355
3 EX-99.2 d372513dex992.htm EX-99.2 186040
4 GRAPHIC g372513g1020004243461.jpg GRAPHIC 4677
5 GRAPHIC g372513g1020004243802.jpg GRAPHIC 5040
6 GRAPHIC g372513g1020004244084.jpg GRAPHIC 2513
  Complete submission text file 0001193125-22-266322.txt   242082
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Filer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38452 | Film No.: 221322177
SIC: 2834 Pharmaceutical Preparations